Gamco Investors INC. ET AL Buys New Position in Nevro Corp (NVRO)
Gamco Investors INC. ET AL bought a new stake in shares of Nevro Corp (NYSE:NVRO) during the 4th quarter, Holdings Channel reports. The fund bought 6,000 shares of the medical equipment provider’s stock, valued at approximately $414,000.
Several other institutional investors and hedge funds have also bought and sold shares of NVRO. Hershey Trust Co. purchased a new stake in Nevro in the fourth quarter worth $119,000. Ameritas Investment Partners Inc. grew its stake in Nevro by 17.3% in the second quarter. Ameritas Investment Partners Inc. now owns 2,432 shares of the medical equipment provider’s stock worth $181,000 after purchasing an additional 358 shares during the period. PNC Financial Services Group Inc. purchased a new stake in Nevro in the second quarter worth $190,000. Los Angeles Capital Management & Equity Research Inc. purchased a new stake in Nevro in the third quarter worth $211,000. Finally, Sterling Capital Management LLC purchased a new stake in Nevro in the second quarter worth $233,000.
Shares of Nevro Corp (NYSE:NVRO) opened at $75.99 on Wednesday. The company has a quick ratio of 6.81, a current ratio of 8.78 and a debt-to-equity ratio of 0.59. Nevro Corp has a 1-year low of $65.00 and a 1-year high of $99.63. The company has a market capitalization of $2,238.71, a price-to-earnings ratio of -52.41 and a beta of -0.59.
WARNING: This story was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2018/02/14/gamco-investors-inc-et-al-buys-new-position-in-nevro-corp-nvro.html.
Nevro Corp. is a global medical device company. The Company focuses on providing products that improve the quality of life of patients suffering from chronic pain. The Company has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain.
Want to see what other hedge funds are holding NVRO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nevro Corp (NYSE:NVRO).
Receive News & Ratings for Nevro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro and related companies with MarketBeat.com's FREE daily email newsletter.